News about product and service launches
Informatics Tools Help Scientists Access, Aggregate and Analyze Drug Compound and Clinical Trial Data WALTHAM, Mass. — July 22, 2020 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that it has launched two online, free-access Perkin Elmer COVID-19 Data Dashboards to help the global scientific community accelerate the... Read more
MINNEAPOLIS, July 21, 2020 /PRNewswire/ — Bio-Techne Corporation (NASDAQ:TECH) today announced that Exosome Diagnostics, a Bio-Techne brand, has completed validation testing for COVID-19 caused by the novel coronavirus (SARS-CoV-2) and now offers the ExoCovid-19 test for detection of the virus in patient samples. The ExoCovid-19 test will be performed in its CLIA-certified, CAP-accredited laboratory. Exosome Diagnostics, the... Read more
Fully automated kit detects human antibodies of immunoglobulin class IgG to help identify individuals with adaptive immune response WALTHAM, Mass.–(BUSINESS WIRE)–Jul. 21, 2020– PerkinElmer, Inc. (NYSE:PKI), a global leader committed to innovating for a healthier world, today announced the launch of a dry blood spot (DBS) based test for SARS-CoV-2 IgG using its GSP®/DELFIA® platform,... Read more
Expanding research tools to detect small non-coding RNAs in situ by combining molecular information with spatial context. MINNEAPOLIS, July 20, 2020 /PRNewswire/ — Bio-Techne Corporation (NASDAQ:TECH) today announced the expansion of the RNAscope™ platform with the release of the miRNAscope™ Assay. The RNAscope technology is an advanced in situ hybridization assay for the spatial visualization... Read more
Perten Glutomatic® 2000 System delivers touchscreen UI, automation and LIMS-connectivity WHAT: PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today launched the Perten Glutomatic® 2000 System for gluten quantity and quality testing of wheat, durum, semolina and flour. The solution features the new Perten Glutomatic 2000 instrument with a modern user... Read more
LANSING, Mich., July 15, 2020 — NEOGEN Corporation (NASDAQ: NEOG) announced today that it has launched an advanced test system that automatically detects microorganisms in a fraction of the time of traditional testing methods. NEOGEN’s new Soleris® Next Generation (NG) can rapidly detect a wide variety of microorganisms that can threaten the safety and quality of food... Read more
End-to-end automatic cultivation of adherent stem cells and derivatives from a single instrument BERGISCH GLADBACH, 14 July 2020 – Miltenyi Biotec announced the immediate availability of its new CliniMACS Prodigy® Adherent Cell Culture System. A flexible architecture specifically developed for the GMP-compliant CliniMACS Prodigy Platform, it enables the automated, scalable, and closed manufacturing of various... Read more
Roche will obtain co-development and co-commercialisation rights for pralsetinib, an investigational, precision therapy in late-stage development for people with RET-altered non-small cell lung cancer, various types of thyroid cancer and other solid tumours. Blueprint Medicines and Roche will collaborate on the development of pralsetinib. Roche and Blueprint Medicines will co-commercialise pralsetinib in the US while... Read more
Basel, 13 July 2020 Second interim analysis of the STASEY study, including data from 193 patients, consistent with results from phase III HAVEN studies, with no new safety signals identified1,2,3 STASEY is the largest open-label study primarily assessing safety and tolerability of a medicine for haemophilia A with factor VIII inhibitors A separate analysis also... Read more
System represents peak in sensitivity and enables customers to Go Beyond current limits July 09, 2020 Framingham, MA — SCIEX a global leader in life science analytical technologies, launches the next generation of its flagship nominal mass spectrometer, the SCIEX Triple Quad™ 7500 LC-MS/MS System – QTRAP® Ready. This system delivers the highest level of sensitivity in the... Read more